학술논문
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
Document Type
Article
Author
Arrieta, V.A.; Kane, J.R.; Kang, S.J.; Dmello, C.; Lee-Chang, C.; Shilati, J.; Chen, L.; Gould, A.; Zhang, D.; Amidei, C.; Yamaguchi, J.T.; Stupp, R.; Heimberger, A.B.; Horbinski, C.; Sonabend, A.M.; Chen, A.X.; Zhao, J.; Rabadan, R.; Kassab, C.; Ling, X.; Yuan, J.; Zhao, W.; Sims, P.; Burdett, K.B.; Zhang, H.; Upadhyayula, P.S.; Bruce, J.N.; Jaishankar, D.; Burks, J.K.; Laffleur, B.; Rothschild, G.; Basu, U.; Lukas, R.V.; Cieremans, D.; Iwamoto, F.M.; McCord, M.; Brat, D.J.; Cooper, L.A.D.; Zhang, B.; Cloughesy, T.F.; Prins, R.; Canoll, P.
Source
In: Nature Cancer . (Nature Cancer, December 2021, 2(12):1372-1386)
Subject
Language
English
ISSN
26621347